Analyst Ratings For IDEXX Laboratories
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for IDEXX Laboratories (NASDAQ:IDXX) in the latest quarter, with a combination of bullish and bearish perspectives. The average 12-month price target has decreased by 5.74% to $564.0. Key analysts have adjusted their ratings and price targets, reflecting their reactions to recent market conditions and company performance.
July 25, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have provided mixed ratings for IDEXX Laboratories, with a combination of bullish and bearish perspectives. The average 12-month price target has decreased by 5.74% to $564.0. Key analysts have adjusted their ratings and price targets, reflecting their reactions to recent market conditions and company performance.
The mixed ratings and the decrease in the average 12-month price target indicate a neutral short-term impact on IDEXX Laboratories' stock price. While some analysts remain bullish, others have lowered their ratings and price targets, reflecting uncertainty in the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100